| Period | Weighting | Quarter | ||||||
|---|---|---|---|---|---|---|---|---|
| Company | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
| GROUP ONE TRADING, L.P. | 41 | 41 | 0.01% | 0.09% | 0.47% | Q3 2013 | Q3 2023 | 41 |
| SIMPLEX TRADING, LLC | 36 | 36 | 0.00% | 0.01% | 0.02% | Q4 2014 | Q3 2023 | 36 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 21 | 21 | 0.00% | 0.00% | 0.00% | Q3 2018 | Q3 2023 | 21 |
| JPMORGAN CHASE & CO | 5 | 1 | 0.00% | 0.00% | 0.01% | Q2 2016 | Q2 2023 | 19 |
| Timber Hill LLC | 11 | 7 | 0.00% | 0.02% | 0.12% | Q2 2013 | Q4 2017 | 18 |
| Citadel Advisors | 13 | 13 | 0.00% | 0.00% | 0.01% | Q2 2013 | Q2 2016 | 13 |
| SG Americas Securities, LLC | 8 | 2 | 0.00% | 0.00% | 0.00% | Q1 2015 | Q4 2020 | 12 |
| IMC-Chicago, LLC | 3 | 1 | 0.00% | 0.00% | 0.01% | Q4 2018 | Q2 2023 | 8 |
| Worth Venture Partners, LLC | 5 | 1 | 0.00% | 0.02% | 0.06% | Q1 2019 | Q3 2022 | 7 |
| JANE STREET GROUP, LLC | 6 | 6 | 0.00% | 0.01% | 0.01% | Q2 2022 | Q3 2023 | 6 |
| Maven Securities LTD | 4 | 1 | 0.01% | 0.09% | 0.26% | Q2 2020 | Q4 2021 | 5 |
| SABBY MANAGEMENT, LLC | 4 | 4 | 0.26% | 0.66% | 1.26% | Q1 2015 | Q4 2015 | 4 |
| WELLS FARGO & COMPANY/MN | 3 | 3 | 0.00% | 0.00% | 0.00% | Q2 2021 | Q4 2021 | 3 |
| Hudson Bay Capital Management LP | 1 | 1 | 0.04% | 0.11% | 0.16% | Q3 2015 | Q2 2017 | 3 |
| BOOTHBAY FUND MANAGEMENT, LLC | 2 | 1 | 0.03% | 0.06% | 0.10% | Q1 2019 | Q1 2020 | 3 |
| HBK INVESTMENTS L P | 2 | 2 | 0.01% | 0.01% | 0.01% | Q2 2019 | Q3 2019 | 2 |
| SOCIETE GENERALE | 1 | 1 | 0.00% | 0.00% | 0.00% | Q2 2016 | Q2 2016 | 1 |
| ADVENT CAPITAL MANAGEMENT /DE/ | 1 | 1 | 0.00% | 0.00% | 0.00% | Q3 2017 | Q3 2017 | 1 |
| Marathon Trading Investment Management LLC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2020 | Q3 2020 | 1 |
| Pentwater Capital Management LP | 1 | 1 | 0.04% | 0.04% | 0.04% | Q3 2013 | Q3 2013 | 1 |
This page lists all the filers that currently own BIOMARIN PHARMACEUTICAL INC or have owned BIOMARIN PHARMACEUTICAL INC in the past.